A detailed history of Axa S.A. transactions in Natera, Inc. stock. As of the latest transaction made, Axa S.A. holds 258,261 shares of NTRA stock, worth $43.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
258,261
Previous 265,120 2.59%
Holding current value
$43.2 Million
Previous $28.7 Million 14.33%
% of portfolio
0.1%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $670,467 - $889,406
-6,859 Reduced 2.59%
258,261 $32.8 Million
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $4.71 Million - $6.22 Million
-55,222 Reduced 17.24%
265,120 $28.7 Million
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $5.79 Million - $9.08 Million
-97,787 Reduced 23.39%
320,342 $29.3 Million
Q4 2023

Jul 16, 2024

BUY
$37.55 - $62.64 $3.67 Million - $6.13 Million
97,787 Added 30.53%
418,129 $26.2 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $2.88 Million - $4.81 Million
76,762 Added 22.49%
418,129 $26.2 Million
Q3 2023

Nov 14, 2023

BUY
$43.4 - $62.52 $14.8 Million - $21.3 Million
341,367 New
341,367 $15.1 Million
Q1 2021

May 14, 2021

SELL
$91.47 - $124.36 $5.87 Million - $7.98 Million
-64,150 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$66.66 - $111.74 $6.63 Million - $11.1 Million
-99,450 Reduced 60.79%
64,150 $6.38 Million
Q3 2020

Nov 13, 2020

SELL
$45.89 - $72.67 $462,158 - $731,859
-10,071 Reduced 5.8%
163,600 $11.8 Million
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $1.67 Million - $3.15 Million
63,260 Added 57.3%
173,671 $8.66 Million
Q1 2020

May 15, 2020

SELL
$17.27 - $40.17 $11,553 - $26,873
-669 Reduced 0.6%
110,411 $3.3 Million
Q4 2019

Feb 18, 2020

SELL
$32.1 - $40.4 $1.82 Million - $2.29 Million
-56,635 Reduced 33.77%
111,080 $3.74 Million
Q2 2019

Aug 13, 2019

BUY
$17.75 - $27.58 $2.98 Million - $4.63 Million
167,715 New
167,715 $4.63 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.